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Laser scanning confocal microscopySaliva contains hundreds of small proline-rich peptides most of which derive from the post-translational and
post-secretory processing of the acidic and basic salivary proline-rich proteins.
Among these peptideswe found that a 20 residue proline-rich peptide (p1932), commonly present in human sa-
liva and patented for its antiviral activity, was internalized within cells of the oral mucosa. The cell-penetrating
properties of p1932 have been studied in a primary gingival ﬁbroblast cell line and in a squamous cancer cell
line, and compared to its retro-inverso form. We observed by mass-spectrometry, ﬂow cytometry and confocal
microscopy that both peptideswere internalized in the two cell lines on a time scale ofminutes, being the natural
form more efﬁcient than the retro-inverso one. The cytosolic localization was dependent on the cell type: both
peptide forms were able to localize within nuclei of tumoral cells, but not in the nuclei of gingival ﬁbroblasts.
The uptakewas shown to be dependent on the culture conditions used: peptide internalizationwas indeed effec-
tive in a completemedium than in a serum-free one allowing the hypothesis that the internalization could be de-
pendent on the cell cycle. Both peptideswere internalized likely by a lipid raft-mediated endocytosis mechanism
as suggested by the reduced uptake in the presence of methyl-ß-cyclodextrin. These results suggest that the nat-
ural peptidemay play a rolewithin the cells of the oral mucosa after its secretion and subsequent internalization.
Furthermore, lack of cytotoxicity of both peptide forms highlights their possible application as novel drug deliv-
ery agents.
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The proline-rich peptides are an interesting and heterogeneous
group of molecules characterized by the presence of a high percentage
of proline residues, feature that confer them peculiar structural and
functional characteristics [1]. They are present not only in saliva, but
also in diverse body cells, tissues and compartments such as skin [2],
tears [3], colostrum [4] and neurohypophysis secretion granules [5].
They were ﬁrstly discovered to possess antimicrobial activities [6],
further, they were recognized as modulator of transduction signals
and inter-molecular interactions [7,8]. One of the characteristics of
some proline-rich peptides is their ability to cross the cell membrane
without a damage [9] and exploiting their activity intracellularly,
interactingwithmolecular targets represented by speciﬁc proteinmod-
ules [10,11]. Furthermore, in the cell penetrating peptide (CPP) pano-
rama, the proline-rich peptides are considered promising tools for the
drug delivery [12,13]. CPPs are widely studied for their ability to enter
2869G. Radicioni et al. / Biochimica et Biophysica Acta 1848 (2015) 2868–2877cells without disrupting or damaging the plasma membrane, and this
feature is used for the design of cargoes for the delivery of bioactive
molecules (e.g.: other peptides, RNA, DNA, antibodies) or drugs [14].
The small salivary proline-rich peptides mainly derive from the proteo-
lytic cleavage process of the – acidic and basic– salivary proline-rich
proteins (PRPs), which occur before granule storage and during and
after granule secretion under the action of a complex set of endo- and
exo-proteinases. The main cleavage site of PRPs is represented by the
Gln-Gly site and as a consequence of this, hundreds of peptides showing
highly similar and, often, overlapping sequences are generated. A great
effort has been done to deﬁne the salivary peptidome [15], which is
estimated to comprise more than 2000 peptides with an important
qualitative contribution of other sources, such as the epithelial cells
and themicrobiome [16], being only 400–600 directly derived from sal-
ivary glands [17–19]. Despite these abundant structural data, no speciﬁc
biological role has been assigned yet to anyone of these peptides. In this
view the hypothesis that even some salivary proline-rich peptides may
be internalized and exerting their function inside the cells of oralmuco-
sa, is intriguing. The peptide p1932 (NH2-GPPPQGGNKPQGPPPPGKPQ),
is commonly found in human saliva [19] and its characteristics, such as
the basic character and the small dimensions, are compatible with the
ability to enter cells. In this studywe have investigated different aspects
of this peptide related to its cellular uptake in an oral squamous cancer
cell line and in a primary gingival ﬁbroblast cell line. The uptake rates
and cytosolic distribution of p1932 peptide and of its retro-inverso
counterpart (R.I.-p1932) have been also investigated and compared.
The results obtained let us to hypothesize that p1932may be consid-
ered as a natural cell-penetrating peptide whose biological function
may be exploited once inside the cells.
2. Materials and methods
2.1. Peptide synthesis and labeling
P1932, R.I.-p1932 peptides and penetratin were assembled on an
Applied Biosystem Peptide Synthesizer 433A (Foster City, CA, USA) on
a preloaded proline-2-chlorotrityl resin (Novabiochem, Laufelﬁngen,
CH) following the Fmoc-(Nα-9-ﬂuorenylmethyloxycarbonyl) protocol
for stepwise solid phase peptide synthesis [20]. Fmoc-amino acids
were from Novabiochem. All couplings were carried out with 5 fold
excess of activated amino acid in the presence of 10 equivalents of N-
ethyldiisopropyl amine, using N-[(dimethylamino)-1-H-1,2,3-triazole-
[4,5-β] pyridine-1-ylmethylene]-N-methylmethanaminium hexaﬂuoro-
phosphate N-oxide (HATU, PE Biosystems, Inc., Warrington, UK) as
activating agent for the carboxy group. The ﬂuoresceinated peptides
were obtained by extending the N-termini of an aliquot (15%) of the
assembled peptide-resin with 8-(9-ﬂuorenyloxycarbonyl-amino)-3,6-
dioxaoctanoic acid, removal of the Fmoc protecting group and coupling
of FAM, mediated with 1-hydroxybenzotriazole and N, Nʹ-diisopropyl-
carbodiimide. The ﬂuoresceinated peptide was released from the resin
and puriﬁed by the same procedures adopted for the free-peptide. At
the end of peptide chain assembly, the peptide was cleaved from
the resin by treatment with a mixture of 80% triﬂuoroacetic acid,
5% water, 5% phenol, 5% thioanisole, 2.5% ethanedithiol and 2.5%
triisopropylsilane for 3 h, with concomitant side chain deprotection.
After ﬁltration of the resin the peptide was precipitated in cold tert-
butylmethyl ether. After centrifugation and washing with tert-
butylmethyl ether the peptide was suspended in 5% aqueous acetic
acid and lyophilized. Analytical and semipreparative Reversed Phase
High Performance Liquid Chromatography (RP-HPLC) was carried out
on a Tri Rotor-VI HPLC system equipped with a MD-910 multichannel
detector for analytical purposes or with a Uvidec-100-VI variable UV
detector for preparative purpose (all from JASCO, Tokyo, Japan). Analyt-
ical RP-HPLC was performed on a Jupiter 5 μm C18 300 Å column
(150 × 4.6 mm, Phenomenex, Torrance CA, USA). Semipreparative RP-
HPLC was performed on a Jupiter 10 μm C18 300 Å (250 × 21.2 mm,Phenomenex, Torrance CA, USA). Linear gradients of acetonitrile in
aqueous 0.1% TFA (v/v) were used to elute bound peptide. MALDI-TOF
mass spectrometry analyses performed on an Autoﬂex workstation
(Bruker Daltonics, Bremen, DE) conﬁrmed the theoretical mass of the
peptide.
2.2. Cell cultures
Unless otherwise speciﬁed, all chemicals and reagents used in this
section were obtained from Sigma (Milan, Italy). PE/CA-PJ15 cells
(ECACC, Porton Down, UK) were cultured at 37 °C in a humidiﬁed envi-
ronment (5% CO2) in IDMEM supplementedwith 10% FCS, 500 units/mL
penicillin, 10 mg/mL streptomycin, 20 mML-glutamine. HGFs were
obtained (with informed consent) from a healthy patient subjected to
gingivectomyof themolar region. Immediately after removal the tissues
were placed in HBSS solution with penicillin (250 U/mL), streptomycin
(0.25 mg/mL), gentamycin (0.05 mg/mL), and amphotericin B
(0.0025 mg/mL). The epithelial layer was detached mechanically and
the sub-epithelial specimens were plated in tissue culture ﬂasks with
DMEM, supplementedwith 50% FCS, L-glutamine (2mM), sodiumpyru-
vate (1 mM), penicillin (50 UI/mL) and streptomycin (50 μg/mL), at 37
°C in a 5% humidiﬁed CO2 atmosphere. After the ﬁrst passage, the hGFs
were routinely cultured in DMEM supplemented with 10% FCS [21–23]
and were not used beyond the ﬁfth passage [24]. Cell synchronization
was performed culturing the cells in a serum free medium for 24 h.
2.3. Cytotoxicity and membrane perturbation assays
Cytotoxic of p1932 and R.I.-p1932 was evaluated on PE/CA PJ15 and
hGF cell lines by means of MTS (Promega, Madison, WI, USA) and NRU
tests. Lyophilized peptideswere dissolved in basalmedium checking for
the ﬁnal pH. Cells (1 × 104) suspended in 200 μL of basal medium, were
seeded in individual wells of a 96-well microplate and cultured to sub-
conﬂuent monolayer for 24 h. Cell viability was evaluated at 24 h, 48 h,
and 72 h after the addition of increasing concentrations (2.5, 5, 10, 20,
50 and 100 μM) of the peptides at 37 °C. NRU assay was performed
according to [25] reading the absorbance at 540 nm. MTS assay was
performed accordingly to manufacture protocols. Absorbance values
were measured using an automatic microplate photometer (Packard
Spectracount™, Packard BioScience Company, Meriden, CT, USA). Each
experiment was performed in sextuplicate.
Dimyristoyl-phosphatidyl glycerol (DMPG), phosphatidylcholine
(PC) and 10,12-Tricosadiynoic acid (polydiacetylene PDA) andmelittin,
were all purchased from Sigma-Aldrich. Melittin was used as a positive
control. Phospholipid vesicles were prepared as described [9,26]. The
resulting vesicles exhibited an intense blue color. The experiments
were performed with a spectrophotometer (Agilent 8453, Santa Clara,
CA) following the signals at 500 and 640 nm in the time. In order to
quantitatively evaluate the colorimetric response the extent of blue-
to-red color transition was calculated by the colorimetric response
(%CR), which is deﬁned as:
%CR ¼ PB0−PBIð Þ=PB0½   100 ð1Þ
where PB = A640 / (A640 + A500), A is the absorbance either at 640 nm
(blue color) or at 500 nm (red component) in the UV–vis spectrum, PB0
is the red/blue ratio of the control sample (before induction of color
change), and PBI is the value obtained after the addition of peptides to
the vesicle solutions.
2.4. MALDI-TOF analysis of internalization
Cells were seeded into 6-well culture plates (Falcon, BD Bioscience,
Milan, Italy) and held for 48 h in a medium supplied with serum.
200 μL of a 100 μM peptide solution was applied for 30 min at 37 °C,
5% CO2 (ﬁnal concentration of the peptide 20 μM). After rinsing with
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lution (0.05% trypsin, 0.02% EDTA w/v) and pronase before lysis, then
washed twice with PBS, and centrifuged at 4000 rpm for 10 min at 4
°C. Cell pellets were suspended in 200 μL of lysis buffer (Tris 10 mM,
EDTA 1mM, pH 7.5) added of Protease Inhibitor Cocktail (Sigma), incu-
bated for 1 h at 4 °C and then sonicated for 15min. Finally, sampleswere
centrifuged at 9000 rpm for 5 min at 4 °C. To remove contaminating
salts and to concentrate, samples were cleaned with C-18 Zip-Tips
(Millipore, Billerica, MA, USA) and 1 μL of the resulting solution was
mixed (1:1 v/v) with 0.3% α-hydroxy-cinnamic acid and spotted on a
stainless MALDI-TOF target until dryness. Spectra were collected in a
positive linear mode with a laser frequency of 5 Hz. At least 300 scans
have been integrated to optimize the signal/noise ratio.
2.5. Flow cytometry
Exponentially growing cells were dissociated with trypsin, and
5 × 105 cells were plated and cultured overnight on 30 mm plates.
The culture medium was discarded and cells were washed twice with
PBS. The cell monolayer was incubated with peptides (20 μM ﬁnal con-
centration) dissolved in FCS free medium for the appropriate exposure
time (5, 15, 30 min). After incubation cells were rinsed twice with PBS
and then dissociated with trypsin. Cell suspension was centrifuged at
1500 rpm for 5 min. The cell pellet was washed twice with DPBS and
then suspended in 250 μL of PBS. Samples were then analyzed on the
FACScan ﬂow cytometer. For the synchronized cells the protocol was
the same but cells were cultured in FCS free medium. The ﬂuorescence
emission was collected through a 670 nm band-pass ﬁlter and acquired
in “log” mode. At least 10.000 events were analyzed. The ﬂuorescence
content was evaluated as ﬂuorescence intensity, expressed as mean
ﬂuorescence channel (MFC). The analysis was performed by the
CellQuest TM software (BD Bioscience,Milan, Italy). Values are reported
as mean values obtained from 3 independent experiments. For the
synchronized cell the protocol was the same but cells were cultured
for 24 h in a FCS free medium.
2.6. Laser scanning confocal microscopy
To investigate the intracellular distribution of p1932 and R.I.-p1932
in the different cell lines, PJ15 and gingival ﬁbroblast cells were ana-
lyzed by LSCM. Observations were performed by using a Leica TCS SP2
laser scanning confocal microscope (Leica Microsystems, Mannheim,
Germany). Exponentially growing cells were dissociated with trypsin,
and 7 × 104 cells were plated and cultured overnight in μ-Slide 8 well
(Ibidi, Planegg, Germany). The culture medium was discarded and
cells were washed twice with DPBS. The cell monolayer was incubated
with peptides (10 μM) dissolved in FCS freemedium for the appropriate
exposure time. After incubation cells were rinsed twice with DPBS and
left in DPBS added with 10% glucose for the observation of the living
cells. External peptide ﬂuorescence was quenched with a trypan blue
solution [27]. As a negative control, non-treated cells and cells incubated
with 5-carboxyﬂuorescein (FAM) alone were also analyzed. Labeled
p1932 and R.I.-p1932 ﬂuorescence was excited at 488 nm and collected
in a 500–535 nm emission window. Fluorescence emissions were col-
lected after passage through a DD488/543 ﬁlter. Images were processed
by using LCS software (Leica Microsystems).
2.7. Uptake inhibition experiments
All inhibitors were obtained from Sigma, and the following inhibitor
concentrations were employed: 30 μM chlorpromazine hydrochloride,
2.5 mMmethyl-β-cyclodextrin, 10 μMheparin sodium salt all dissolved
in Millipore water H2O, while 10 μM cytochalasin-D was dissolved in
DMSO at a concentration of 5mg/mL and subsequently diluted inMilliQ
water in order to obtain a ﬁnal operative concentration of DMSO of 0.1%.
Cells (5 × 103) were seeded in a 96 well microplate and incubated withinhibitors for 30 min in a serum-free medium; thereafter, proline-rich
peptides were added (ﬁnal peptide concentration 10 μM) and cells
further incubated for 30 min. Excess of peptides and inhibitors was
removed by rinsing twice with DPBS and external ﬂuorescence was
quenched by treating the cells for 1 min with trypan blue and subse-
quent washing. Finally, cells were treated with proteases (trypsin and
pronase) and lysed with RIPA buffer. The resulting lysates were centri-
fuged at 12,000 rpm × 15 min to remove cell debris and the superna-
tants were collected and read in a Glomax (Promega, Madison, WI,
USA) multiwell reader device using a ﬂuorescence module with a
570 nm ﬁlter. Experiments of uptake at 4 °C were performed and
followed by FC. Cells were left to equilibrate at this temperature
for 15 min after while the peptides (20 μM ﬁnal concentrations) were
incubated and the internalization was followed in for 30 min (checks
at 0, 15 and 30 min). Then, cells were placed at 37 °C and FC analyses
were performed again at 0, 15 and 30 min. The data are the results of
triplicate experiments.
2.8. Statistical analysis
Data are shown as mean ± standard deviation. Statistical signiﬁ-
cances were analyzed by ANOVA with a signiﬁcance of b0.05 for
P values. A Dunnett's test (P b 0.05) was performed on the full data set
to compare values of control experiments with all other groups.
3. Results
3.1. p1932 and R.I.-p1932 are internalized within cells
In order to qualitatively evaluate the internalization of p1932 and its
retro-inverso analogous, a MALDI-TOF mass spectrometry method has
been employed. PE/CA PJ15 an oral squamous cancer cell line and pri-
mary human gingival ﬁbroblasts (hGFs) were incubated in the presence
of either p1932 or R.I.-p1932 peptides for 30min; themass spectra anal-
ysis of the cell lysates revealed that both the peptides were internalized
after this time period (Fig. 1).
To quantitatively determine in a scale time the uptake of the two
peptides, ﬂow cytometry (FC) measurements were carried out. The
extent of internalization was determined from the ratio between the
intensity of ﬂuorescence measured after peptide exposure and the
control experiments. The FC measurements, even though slightly
overestimated due to residual membrane-bound peptide fraction, re-
vealed that the entry of the two peptide forms began already after
5 min upon incubation (Fig. 2A and B), an effect more evident in not
synchronized cells.
In the following 30 min, a continuous linear increase of the ﬂuores-
cence was observed indicating a constant entry of the peptides. The in-
crease of ﬂuorescence of p1932 peptide was faster in the PJ15 cell line
than in hGFs, at least within the ﬁrst 15 min, but the amount of peptide
internalized after 30minwas comparable in both cell types (Fig. 2A). In-
ternalization of the retro-inverso form resulted to be slower than p1932
in the same time of observation (Fig. 2B) in both cell types.
In order to conﬁrm the above results and to observe the intracellular
distribution of p1932 and of its R.I. form, we used laser scanning confo-
calmicroscopy (LSCM), andwe operated on living cells in order to avoid
artifacts due to the ﬁxation [28]. The images (optical sections) were
taken after 30 min and 1 h upon 10 μM peptide treatment and after
quenching extracellular ﬂuorescence with a trypan blue solution in
order to avoid a green background due to the peptide excess (Fig. 3).
The green signal represents carboxyﬂuorescein-p1932 (FAM-p1932)
or FAM-R.I.-p1932 (excitation 488 nm, emission 500–535 nm). LSCM ob-
servations of hGFs showed that p1932was present after 30min in diffuse
punctuate structures (vesicles) distributed in a perinuclear pattern; after
60 min the ﬂuorescence was more homogeneous, but nuclei still
appeared almost completely negative for ﬂuorescence (Fig. 3, panels 1
and 2). In PE/CA PJ15 cells after 30 min, many punctuate structures
Fig. 1.MALDI-TOF-MS analysis of cells treatedwith p1932 and R.I.-p1932. MALDI-TOF-MS spectra of cell lysateswere taken after 30min upon treatmentwith 20 μM(ﬁnal concentration)
of each peptide. Each sample, after lysis, was concentrated and puriﬁed with Zip-Tip C18 andmixedwith an HCCAmatrix solution. Panel A: PE/CA PJ15 cells, control; Panel B: PE/CA PJ15
cells treated with p1932; Panel C: PE/CA PJ15 cells treated with R.I.-p1932. Panel D: hGF cells, control; Panel E: hGF cells treated with p1932; Panel F: hGF cells treated with R.I.-p1932.
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cytoplasmic organelles and nuclei, where after 60min, p1932was highly
visible (Fig. 3, panels 5 and 6).
In a similar fashion to p1932, the retro-inverso form did not enter
hGF nuclei (Fig. 2, panels 3 and 4), while it entered nuclei of PJ15 even
if in a lesser extent if compared to p1932 (Fig. 2, panels 7 and 8). An
endocytic uptake is suggested also for R.I.-p1932 due to the presence
of many vesicles visible in both the cell lines.
A comparison with penetratin, a well-known cell-penetrating pep-
tide employed in several studies as a cargo for the delivery of biological
active molecules [29–31] was also carried out. As a result, penetratin
showed a punctuate distribution nearby the plasma membrane and in
the cytosol both in PJ15 cells and in hGFs (Fig. 3, panels 9–12). At
60 min a more diffuse distribution could be appreciated in hGFs differ-
ently from the punctuate patterns observed in PJ15.
3.2. The medium composition affects peptide uptake
Interesting results were observed comparing the effects of using a
complete medium and a serum freemedium. The two proline-rich pep-
tide forms were separately incubated with PJ15 cells and hGFspreviously maintained in a serum-free medium for 24 h, in this way,
the cells have been blocked in their cell cycle. As a result, in the serum
free condition the internalization process was dramatically reduced in
both the cell lines and with both the peptide forms (Fig. 2A and B).
More precisely, after 30 min the amount of p1932 within the cells was
reduced by 80% in hGFs and by 75% in PJ15 cells (Fig. 2A and B), while
R.I.-p1932 amount was lowered almost of the 60% in hGFs and 80% in
PJ15 cells (Fig. 2A and B). For the calculation of the internalization
rate, the amount of death cells due to serum-free medium treatment
was taken in account.
3.3. Effect of endocytosis inhibitors on peptide internalization
To shed more light on the internalization processes involving p1932
and R.I.-p1932, we performed a series of uptake experiments at differ-
ent temperatures and in the presence of speciﬁc inhibitors of various
endocytosis pathways. The effect of temperature on peptide uptake
was investigated performing experiments at 4 °C for 30min and follow-
ed bymeans of FC. As a result, the internalization rates of p1932 and R.I.-
p1932were lowered by at least 70% in both cell lines, if compared to the
rates measured at 37 °C (Fig. 4, inset).
Fig. 2. Penetration rates of p1932 (A) and R.I.-p1932 (B)measured by FC. Theﬂuorescence
emission was collected through a 670 nm band-pass ﬁlter and acquired in “log” mode.
Black lines represent the internalization rate in cells grown in a complete medium (not
synchronized cells), while gray lines are representative of cells grown for 24 h in a
serum-free medium (synchronized cells) at 37 °C, 5% CO2 atmosphere. Peptides were
used at 20 μM concentration. As a negative control, non-treated cells were also analyzed.
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ization rates, more evident for p1932, could be observed in the follow-
ing minutes. The different kinetic proﬁles registered with respect to
the experiments shown in Fig. 2 may be likely due to the “in course”
restoring to the standard temperature of the cells system (Fig. 4).
To demonstrate that an energy dependent endocytosis mechanism
was at the basis of the two proline-rich peptide internalization,
we used speciﬁc inhibitors of different uptakemechanisms: chlorprom-
azine for clathrin-mediated endocytosis, cytochalasin-D (Cyt-D) for
macropinocytosis, methyl-β-cyclodextrin (M-β-CD) for lipid raft-
caveolae endocytosis and heparin for heparansulfate dependent uptake.
The results showed that in all the experiments the inhibitors behaved in
a similar way independently from the cell type and from the peptide
form, in particular chlorpromazine and Cyt-D did not affect peptides up-
take while M-β-CD signiﬁcantly inhibited the entry of the proline-rich
peptides both in PJ15 and hGF cells (Figs. 5a, b, c and d).
Heparin had a lower, but signiﬁcant effect on peptide internalization
and to shed light on this last point, we examined if an interaction be-
tween heparin and p1932 and R.I.-p1932 occurred by using a size exclu-
sion chromatography approach. The two peptides were mixed with
increasing heparin amounts in order to have the following peptide:
heparin ratios: 1:1, 1:2, 1:5 and 1:8. As a result, in the conditions used(PBS saline buffer, pH 7.4) a very poor modiﬁcation in the elution
volumes of peptides was seen (Table 1) indicating an absent or, at
least, a weak interaction.
3.4. Cytotoxicity and artiﬁcial vesicle interaction studies
Cytotoxicity of p1932 and R.I.-p1932 was proven by MTS and the
NRU assays against the PJ15 and hGF cell lines in the concentration
range 2.5–100 μM. In any of these conditions, a substantial cytotoxicity
could not be appreciated. Interestingly even the retro-inverso form
showed a slight cytotoxicity at the concentration of 100 μM at which
85% and 82% of viability were measured for hGF and PJ15 cells,
respectively.
The absent or low of cytotoxicity of p1932 and R.I. was also con-
ﬁrmed by the optical microscopy images where any evident morpho-
logical changes could be detected in both the cell lines after 60 min
upon incubation with the peptides (Fig. 3, panels 13–16).
In order to conﬁrm the microscopy data about concerning the
absence of membrane perturbation and hence of a consequent cytotox-
icity, we performed a lipid vesicle perturbation assay based on a colori-
metric method developed by Kolusheva and coll. [26] in which suitable
phospholipids and polydiacetylene (PDA) are mixed to give a UV-light
sensible vesicles. The intact vesicles once activated by UV-light show a
blue coloration that turns pink or red if a perturbation event occurs
as in the case of the presence of a pore-forming peptide. As a result
p1932 and R.I.-p1932 did not show any perturbation effect on artiﬁcial
lipid–PDA vesicles when compared with melittin (Fig. 6), an antimicro-
bial peptide known to kill bacterial cells by a membrane disruptive
pore-forming mechanism of action.
Accordingly with these data a sequence-based analysis of the hy-
dropathy of the p1932 peptide with the freely available MPEx web
tool (http://blanco.biomol.uci.edu/mpex/)was performed.MPEx allows
to explore the topology of membrane proteins by means of hydropathy
plots based upon thermodynamic and biological principles, aswell as to
calculate the theoretical free energy related to the transfer of a peptide
from water to a POPC interface (or vice versa). The transfer free energy
derives from the sum of the free energy contributions calculated on the
basis of the Wimley–White scale [32]. The water–lipid bilayer transfer
free energy valuewas found to be+8.24 kcal/mol for p1932, suggesting
a poor ability of the peptide itself to pass through the biological mem-
brane by passive diffusion.
3.5. Circular dichroism studies
P1932 and its retro-inverso form were analyzed by FAR-UV circular
dichroism in a phosphate buffer (25mM, pH 7.0) at 25 °C and in a 2,2,2-
triﬂuoroethanol (TFE)/phosphate buffer (30%, v/v) solution to mimic
the membrane environment (Fig. 7).
In phosphate buffer the two peptides showed mirror images with a
curve proﬁle typical of an unordered structure characterized by a nega-
tive (for p1932) and a positive (for R.I.-p1932) band at 200 nm. In TFE
30% the spectrum of R.I.-p1932 remained the same, while a slight
change in the conformation of p1932 could be observed represented
by a slight positive increase at 219 nm showing a more susceptibility
of the natural form to the solvent system used and a more structural
ﬂexibility. Interestingly, the positive increase at 219 nm may indicate
an intrinsic propensity of p1932 to adopt a polyproline-II helix structur-
al arrangement.
4. Discussion
The biological role of many salivary peptides is not completely un-
derstood; histatins play important roles in tissue repair events [33],
and are involved in oral defense against pathogens [34] together with
cathelicidin LL-37 and defensins [35]. Statherin together with other
proline-rich proteins is implied in the enamel pellicle formation by
Fig. 3. Intracellular localization of p1932 andR.I-p1932 in PE/CA-PJ15 and hGF cells analyzed by laser scanning confocalmicroscopy. Concentration of peptideswas 10 μM.The imageswere
taken at 30′ and 60′ in order to observe the variable diffusion in the cells. Green signals: FAM-peptide's ﬂuorescence (excitation 488 nm, emission 500–535 nm). From top left to bottom
right: human gingival ﬁbroblasts treated with p1932 (panels 1–2) and with R.I-p1932 (panels 3–4). PE/CA PJ15 cells treated with p1932 (panels 5–6) and with R.I.-p1932 (panels 7–8).
Panels 9–12: experiments performedwith FAM-penetratinwith PJ15 (9–10) and hGFs (11–12). The arrows indicate the cytosolic vesicles containing thepeptides. Bottom images (13–16):
light images of hGF and PJ15 cells treated with proline-rich peptides taken at 60 min upon incubation. Representative images from three independent experiments are shown.
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such as IB-5 characterized by the repetitive sequence -KPQGPPPP-,
seem involved in dietary tannin binding [37]. Hundreds of small-
medium sized proline-rich peptides showing highly overlapping frames
and similar sequences are generated by the pre-and post-secretory
events occurring at the expenses of the salivary basic proline-rich pro-
teins [15–17], but their function is almost still unknown. Among these,
a 20 residues peptide (p1932, NH2-GPPPQGGNKPQGPPPPGKPQ)was al-
ready patented by some of authors of this study for its strong anti-viral
activity [PCT/IB2012/050415].
In consideration of the recognized cell penetrating properties of
other analogy with other amphipathic proline-rich peptides [12],
the present study was focused on the internalization properties of
p1932. We focused on its internalization properties using two oral cell
lines: a primary gingival ﬁbroblast cell line produced in our laboratories
and the PE/CA PJ15 cell line originated from an oral squamous cell car-
cinoma (OSCC) representative of an aggressive head and neck cancer
[38]. p1932 peptide is commonly found in human saliva, derivingfrom the proteolytic processing of the proline-rich proteins PRB1-L
(UniProt/Swiss-Prot P4280), PRB-2L (P02812/Q7M4Q5), PRB1-M
(Q86YA1) [19]. The sequence of p1932 is repeated four times in PRP1-
L and PRB-2L, and three times in PRB1-M, bringing its average concen-
tration in human saliva to 5–10 μM depending on different factors
(day time of collection, sex and age). Interestingly it is also found in
G7N674 fromMacaca mulatta and in G3RMU1 and G3RWV9 in Gorilla
gorilla.
In this study we wanted to study also the retro-D version (R.I.) of
the natural peptide in order to have a structural and a functional com-
parison. The internalization of the p1932 and R.I.-p1932 proline-rich
peptides was initially followed by means of a MALDI-TOF mass
spectrometry approach [39] as it is a quite simple, rapid and sensible
method, and where peptides had necessarily not to be labeled, and
thus preserving their natural structure and physicochemical properties.
From a qualitative point of view themass analysis showed that the nat-
ural peptide and its retro-inverso formwere internalizedwithin the ﬁrst
30 min upon incubation, a reasonable time for consider them as cell-
Fig. 4. Effect of temperature on peptide uptake. The line graph shows the uptake rates analyzed in the time by FC. HGF (black diamonds) and PE/CA PJ15 cells (black squares) treatedwith
p1932. HGF (gray diamonds) and PJ15 cells (gray squares) treatedwith R.I.-p1932. Experiments were carried out at 4 °C at 5%, CO2 atmosphere using a 20 μMpeptide ﬁnal concentration.
The arrow indicates the return to 37 °C condition. To better appreciate the effect of temperature, the inset shows the effect of an exposure for 30 min at 4 °C on peptide uptake.
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formed bymeans of FC where, even considering a slight overestimation
of the cell surface-bound peptide. It was observed that p1932 was rap-
idly internalized by hGFs and tumoral cells within the ﬁrst 15 min
upon incubation, while the R.I. form resulted to be slower, a trend ob-
served also in LSCM images where in the same time lapse, the cytosolic
diffusion of the peptides appeared differently expressed. This aspect
arises the question if the different peptide conﬁguration may inﬂuence
their uptake. Until a few years ago, the paradigm -chirality has no effect
on CPPs uptake- was a rule, but recently this was demonstrated to be
not completely true. In agreement with what observed for p1932 andFig. 5. Effect of uptake inhibitors. The scheme represents the effect of speciﬁc inhibitors on upt
(met-b-CD) for lipid-raft/caveolae mediated endocytosis, chlorpromazine (clprz) for clathrin
B) PJ15 cells treated with p1932 and R.I-p1932 respectively. Schemes C) and D) hGFs treated
the cells and readings. Peptideswere used at a 10 μMconcentration throughout. Control (CTRL)
are representative of the signal emitted by cells alone. Asterisks are representative of the statisR.I.-p1932, it was recently demonstrated that L- and D-polyarginine
peptides may actually show a diverse uptake efﬁciency which was
dependent both on their chirality and on the cell type employed [40].
As reported for the polyarginine peptides [40], L- and retro-D-p1932
may unspeciﬁcally bind heparan-sulfate on the plasma membrane and
then be internalized by a chirality dependent uptake mechanism.
Furthermore, the CD spectra proﬁles of p1932 and R.I.-p1932 taken in
a phosphate buffer, show roughly mirror images, as they evidently
share in this solvent similar secondary structure elements resembling
a random coil arrangement. Nevertheless, in a more hydrophobic envi-
ronment due to the addition of TFE p1932 showed to be more ﬂexibleake mechanisms: heparin for GAGs mediated uptake mechanisms, methyl-β-cyclodextrin
mediated endocytosis and cytochalasin-D (Cyt-D) for macropinocytosis. Schemes A) and
with p1932 and R.I.-p1932 respectively. The ﬂuorescence values were taken after lysis of
experimentswere carried outwith peptideswithout inhibitors. The “no peptides” columns
tical signiﬁcance (** = good, *** = high, P b 0.05).
Table 1
The table shows the elution volumes obtained upon size exclusion chromatography runs
of different mixtures of proline-rich peptides and heparin. The peptides were maintained
at a ﬁxed concentration of 1 mMwhile the amount of heparin was increased as reported.
Control 1:1 1:2 1:5 1:8
p1932 18 18 18 17.5 17.2
R.I.-p1932 19 19 19 18.7 18.3
Fig. 7. Far-UV circular dichroism spectra of p1932 (light gray and black arrows) and
R.I.-p1932 (dark gray arrow) at 25 °C. The peptides (all at 1 mM of concentration) were
suspended in a 25 mM phosphate buffer, pH 7.0 (dotted lines) and in 30% 2,2,2-
triﬂuoroethanol (continuous lines).
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enantio-peptide) ismade up of D-amino acids in a reversed sequence as-
suming a side chain topology similar to that of its natural counterpart,
but with inverted amide peptide bonds. This feature may indeed affect
the peptide structural ﬂexibility as reported for other peptides
[41–43]. Thus, the slower rate of cellular uptake of R.I.-p1932 may also
be due to an affected interaction with the cell membrane apparatus
determined by the structural arrangement of this peptide, an aspect,
which has been considered important for the internalization of CPPs
[44].
It appeared that the different stereochemistry of the peptides also
inﬂuenced their cytosolic distribution, at least in PJ15 cancer cells. The
confocal microscopy images shown that p1932 and more evidently its
isomer, were internalized in vesicles (punctuate structures in the
LSCM images) thus suggesting an endocytic pathway followed by both
the peptides. In the same time lapse (60 min) while p1932 diffuse
more rapidly in the cytosol of PJ15, also occupying the nuclei, the R.I.-
p1932 was still present in vesicles and only partially diffused in the
cytosol and nuclei of PJ15 that consequently showed a less intense ﬂuo-
rescence (Fig. 2). Completely different was the behavior in hGFs, where
both the peptides were internalized by vesicles as demonstrated by the
several punctuate structures in confocal images, and both were exclud-
ed from the nuclei even after 60 min upon exposure.
Thus, to conﬁrm an endocytic pathway for p1932 and R.I.-p1932
uptake, as suggested by LSCM images, we performed experiments at 4
°C and subsequently with selected endocytosis inhibitors. Firstly, we
tried to distinguish if a simple diffusion could be at the basis of
proline-rich peptide uptake, in fact, energy dependent cell mechanisms
such as endocytosis are strongly depleted at 4 °C [45], while diffusion or
translocation is affected in a lesser extent or at all. The reduction of
proline-rich peptide uptake compared to the rates observed at 37 °C
(Fig. 4) strongly conﬁrmed that an energy dependent mechanism was
the main responsible for the peptide uptake also in agreement with
the transfer free energy value obtained by MPEx web tool, indicating aFig. 6. Colorimetric phospholipid vesicle assay. Colorimetric response (%CR) induced by 20 μM
determined. % CR represents the percentage of color transition from blue (integral vesicles) tolow propensity of this peptide to translocate a lipid bilayer for passive
diffusion.
The internalization process is a very complex event and as outlined
above, may be merely divided into two fundamental steps. The ﬁrst
one is the electrostatic interaction between the cationic moieties of a
peptide (arginine and lysine) and the negative charges due to the
polysulfated cell-surface glycosaminoglycan (GAG) polysaccharides
[46,47]. The second step is the deﬁnitive entry, which can occur via
different kinds of endocytosis pathways such as macropinocytosis,
clathrin-dependent endocytosis (CDE) and lipid-raft/caveolae endocy-
tosis. Chlorpromazine, cytochalasin-D, methyl-β-cyclodextrin (M-β-
CD) and heparin are respectively usually employed as inhibitors of
CDE, macropinocytosis, lipid-raft/caveolae endocytosis and binding to
cell-surface GAGs mediated endocytosis [48]. Among these, M-β-CD
had a clear inhibition effect on proline-rich peptide uptake, suggesting
that a lipid raft mediated mechanism was the main way followed by
these peptides for their internalization, in fact, M-β-CD acts as a
cholesterol-sequestering agent and selectively inhibits the lipid raft for-
mation that are deﬁnite regions of the plasma membranes particularly
enriched of sphingolipids and cholesterol [49]. Accordingly to our
data, a lipid raft based mechanism was demonstrated for the entry in
He-La cells of the “sweet arrow” CF-(VRLPPP)3, an amphipathicp1932, R.I.-p1932 and melittin (positive control) on PC/DMPG/PDA vesicles at pH 7.4 was
pink-red (perturbed vesicles) monitored at 640 nm and 500 nm, respectively.
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based on lipid rafts, differently from a clathrin-dependent endocytosis,
is particularly attractive because the CPP is not prone to a lysosomal
degradation as endosomes do not fuse with lysosomes [51]. According-
ly, we did not observe any decrease of the ﬂuorescence in the two cell
lines in a suitable time after peptide exposure due to the release of pep-
tide fragments outside the cells [52]. Heparin showed to be a less effec-
tive inhibitor. Indeed heparin has been used to decrease the binding of
polyarginine CPPs to cell surfaces [53] and GAGs sequestering cationic
peptides,may affect their biological effect [54]. The reason of a lower ef-
fect of heparin on proline-rich peptide internalization could be partially
explained by the poor binding capacity of heparin to the two peptides as
shown by size exclusion chromatography experiments where the elu-
tion volume of either p1932 or R.I.-p1932 did not signiﬁcantly change
upon interaction with increasing amounts of heparin. Although this
aspect should be investigated in more detail, the poor binding may be
explained with a fast equilibrium, and so a weak interaction, occurring
between proline-rich peptides and heparin [55].
Endocytosis and hence peptide internalization are dependent on
cell-cycle events [56]. Fielding and Royle have recently reported that
mitosis completely inhibited the CDE pathway [57]. Interestingly,
when mitosis was blocked by growing cells in a serum-free medium,
the uptake was greatly reduced if compared to not synchronized (repli-
cating) cells. These ﬁndings are in agreement with the inhibitor exper-
iment data and enforce our hypothesis for a clathrin-independent
endocytosis pathway at the basis of the proline-rich peptide uptake
and further suggest that a dynamic rearrangement of the plasmamem-
brane and of the cytoskeleton is determinant for peptide internalization.
Some authors have highlighted how the endocytosis pathway may
differ depending on peptide characteristics and the cell type and differ-
ent pathways have been proposed for cell-penetrating peptide internal-
ization, evidencing a complex framework. Moreover, the same peptide
may follows diverse pathways in the same cell type depending on dif-
ferent factors such as peptide concentration, structure and furthermore
on cell physiological conditions [28,45,48,58]. For example, one of the
critical factors which may affect the uptake pathway is the concentra-
tion of the peptide used. At higher concentrations a perturbation or
even a disruption of the membrane may occur, leading to a passive
entry of the peptide [59]. At the peptide concentrations employed in
this study (10 and 20 μM), that however are near to those found in
the oral cavity in saliva, we could not detect any membrane damage
as evidenced by themicroscopy observations, cytotoxicity, and artiﬁcial
vesicle assays, performed even at concentrations well above those used
in the uptake studies. We also tried to maintain when possible, a con-
stant peptide to cell ratio, another critical point outlined in various
CPP studies [60].
It is noteworthy that the two peptides follow an apparent similar en-
docytosis pathway independently on the cell type even if at different
uptake rates. On the other side, the cytosolic distribution varies depend-
ing on the peptide form and the cell type. While the natural peptide
largely diffuses in the cytosol and in the nuclei of PJ15 cells, the R.I.
form is more conﬁned in the same cells in vesicles and is less present
in the nuclei. In hGFs both the peptides are completely absent in the
nuclei.
These data suggest that nuclear receptors recognizing the proline-
rich peptides, may be expressed in PJ15 cells and not, or in a lesser ex-
tent, in hGFs thus explaining the complete absence of peptide inside
the nuclei of these cells[56]. This aspect is intriguing under an applica-
tive point of view, as these proline-rich peptides may be successfully
used as speciﬁc drug cargoes targeting such tumoral cells.
Although it is beyond the purpose of this study, these results let us to
speculate about the physiological signiﬁcance of p1932 peptide. Its abil-
ity to be internalized within the oral mucosa may allow this peptide
to play potential intracellular functions. This may be intriguing as
many cellular mechanisms are mediated by the interaction of proline
stretches in certain proteins and the Proline-Rich Sequence (PRS)Recognition Domains, which include the SH3, GYF, EVH-1, proﬁlin-
like, andWWdomains [61]. The proline-rich peptide PR39 is a clear ex-
ample as amodulator of intracellular signals involving SH3 domains [7].
Cell proteomes are particularly rich in SH3 domains able to recognize
the PxxP consensus sequences, and basic residues ﬂanking this se-
quence may improve the recognition as well [62]. p1932 possesses
these features and thus it represents a good candidate as an interactor
of PRS domains and hence as a modulator of cell functions.
5. Conclusions
We showed that a salivary proline-rich peptide and its isomeric syn-
thetic form were internalized within normal and tumoral oral mucosa
cell lines. It should be considered that the oral cavity epithelium is con-
tinuously renewed by an exfoliation process, but the internalization
time rates shown by p1932, allow the entry of the peptide in a suitable
time to exert some biological role in the mouth mucosa. In our opinion
the intracellular uptake of p1932 is of great interest in the oral biology,
in fact, the entry within cells of the oral mucosa strongly suggests an
intracellular physiological role of this peptide. These ﬁndings open a
scenario in which p1932 and many peptides similar to it may play
some roles asmodulatormolecules of cell machinery of oral epithelium.
In addition, the L- and retro-inverso proline-rich peptides possess a
series of features that make them potential candidates for applications
as nano-delivery systems. Both peptides offer practical advantages in-
cluding good solubility in water, simplicity of synthesis, resistance to
proteolytic degradation and hence a major bioavailability coupled
with a low cytotoxicity for the D-retro form [41] and, in the case of
p1932, a human origin. Compared to other CPPs, like penetratin used
in this study as a positive control, these peptides represent at least a
good starting point for the design of new biocompatible and efﬁcient
CPPs.
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